A citation-based method for searching scientific literature

Saina Beitari, Qinghua Pan, Andrés Finzi, Chen Liang. J Virol 2020
Times Cited: 5







List of co-cited articles
61 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.
Yoshiko Usami, Yuanfei Wu, Heinrich G Göttlinger. Nature 2015
246
80

The V3 Loop of HIV-1 Env Determines Viral Susceptibility to IFITM3 Impairment of Viral Infectivity.
Yimeng Wang, Qinghua Pan, Shilei Ding, Zhen Wang, Jingyou Yu, Andrés Finzi, Shan-Lu Liu, Chen Liang. J Virol 2017
36
60

Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.
Toshana L Foster, Harry Wilson, Shilpa S Iyer, Karen Coss, Katie Doores, Sarah Smith, Paul Kellam, Andrés Finzi, Persephone Borrow, Beatrice H Hahn,[...]. Cell Host Microbe 2016
103
60

SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins.
Chetan Sood, Mariana Marin, Ajit Chande, Massimo Pizzato, Gregory B Melikyan. J Biol Chem 2017
70
60

The IFITM proteins inhibit HIV-1 infection.
Jennifer Lu, Qinghua Pan, Liwei Rong, Wei He, Shan-Lu Liu, Chen Liang. J Virol 2011
266
60

Effect of HIV-1 Env on SERINC5 Antagonism.
Saina Beitari, Shilei Ding, Qinghua Pan, Andrés Finzi, Chen Liang. J Virol 2017
49
60

IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag.
Yadvinder S Ahi, Diborah Yimer, Guoli Shi, Saliha Majdoul, Kazi Rahman, Alan Rein, Alex A Compton. mBio 2020
11
60

IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity.
Kevin Tartour, Romain Appourchaux, Julien Gaillard, Xuan-Nhi Nguyen, Stéphanie Durand, Jocelyn Turpin, Elodie Beaumont, Emmanuelle Roch, Gregory Berger, Renaud Mahieux,[...]. Retrovirology 2014
84
60

The retroviral accessory proteins S2, Nef, and glycoMA use similar mechanisms for antagonizing the host restriction factor SERINC5.
Iqbal Ahmad, Sunan Li, Rongrong Li, Qingqing Chai, Lixin Zhang, Bin Wang, Changqing Yu, Yong-Hui Zheng. J Biol Chem 2019
12
60

Identification of potential HIV restriction factors by combining evolutionary genomic signatures with functional analyses.
Paul J McLaren, Ali Gawanbacht, Nitisha Pyndiah, Christian Krapp, Dominik Hotter, Silvia F Kluge, Nicola Götz, Jessica Heilmann, Katharina Mack, Daniel Sauter,[...]. Retrovirology 2015
58
60

Functional Mapping of Regions Involved in the Negative Imprinting of Virion Particle Infectivity and in Target Cell Protection by Interferon-Induced Transmembrane Protein 3 against HIV-1.
Romain Appourchaux, Mathilde Delpeuch, Li Zhong, Julien Burlaud-Gaillard, Kevin Tartour, George Savidis, Abraham Brass, Lucie Etienne, Philippe Roingeard, Andrea Cimarelli. J Virol 2019
15
60

HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation.
Annachiara Rosa, Ajit Chande, Serena Ziglio, Veronica De Sanctis, Roberto Bertorelli, Shih Lin Goh, Sean M McCauley, Anetta Nowosielska, Stylianos E Antonarakis, Jeremy Luban,[...]. Nature 2015
241
60

IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
Alex A Compton, Timothée Bruel, Françoise Porrot, Adeline Mallet, Martin Sachse, Marine Euvrard, Chen Liang, Nicoletta Casartelli, Olivier Schwartz. Cell Host Microbe 2014
118
60

Super-Resolution Fluorescence Imaging Reveals That Serine Incorporator Protein 5 Inhibits Human Immunodeficiency Virus Fusion by Disrupting Envelope Glycoprotein Clusters.
Yen-Cheng Chen, Chetan Sood, Mariana Marin, Jesse Aaron, Enrico Gratton, Khalid Salaita, Gregory B Melikyan. ACS Nano 2020
16
60

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.
Jingyou Yu, Minghua Li, Jordan Wilkins, Shilei Ding, Talia H Swartz, Anthony M Esposito, Yi-Min Zheng, Eric O Freed, Chen Liang, Benjamin K Chen,[...]. Cell Rep 2015
101
60

The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry.
Samad Amini-Bavil-Olyaee, Youn Jung Choi, Jun Han Lee, Mude Shi, I-Chueh Huang, Michael Farzan, Jae U Jung. Cell Host Microbe 2013
208
60

IFITM proteins restrict viral membrane hemifusion.
Kun Li, Ruben M Markosyan, Yi-Min Zheng, Ottavia Golfetto, Brittani Bungart, Minghua Li, Shilei Ding, Yuxian He, Chen Liang, James C Lee,[...]. PLoS Pathog 2013
214
60

SIVcol Nef counteracts SERINC5 by promoting its proteasomal degradation but does not efficiently enhance HIV-1 replication in human CD4+ T cells and lymphoid tissue.
Dorota Kmiec, Bengisu Akbil, Swetha Ananth, Dominik Hotter, Konstantin M J Sparrer, Christina M Stürzel, Birthe Trautz, Ahidjo Ayouba, Martine Peeters, Zhong Yao,[...]. PLoS Pathog 2018
14
40

The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild.
Anke Heigele, Dorota Kmiec, Kerstin Regensburger, Simon Langer, Lukas Peiffer, Christina M Stürzel, Daniel Sauter, Martine Peeters, Massimo Pizzato, Gerald H Learn,[...]. Cell Host Microbe 2016
60
40

Plasma Membrane-Associated Restriction Factors and Their Counteraction by HIV-1 Accessory Proteins.
Peter W Ramirez, Shilpi Sharma, Rajendra Singh, Charlotte A Stoneham, Thomas Vollbrecht, John Guatelli. Cells 2019
8
40

The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.
Abraham L Brass, I-Chueh Huang, Yair Benita, Sinu P John, Manoj N Krishnan, Eric M Feeley, Bethany J Ryan, Jessica L Weyer, Louise van der Weyden, Erol Fikrig,[...]. Cell 2009
849
40


A Long Cytoplasmic Loop Governs the Sensitivity of the Anti-viral Host Protein SERINC5 to HIV-1 Nef.
Weiwei Dai, Yoshiko Usami, Yuanfei Wu, Heinrich Göttlinger. Cell Rep 2018
28
40


Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain.
Sara L Sawyer, Lily I Wu, Michael Emerman, Harmit S Malik. Proc Natl Acad Sci U S A 2005
501
40

Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef.
Nicholas J Matheson, Jonathan Sumner, Kim Wals, Radu Rapiteanu, Michael P Weekes, Raphael Vigan, Julia Weinelt, Michael Schindler, Robin Antrobus, Ana S H Costa,[...]. Cell Host Microbe 2015
117
40

IFITM3 directly engages and shuttles incoming virus particles to lysosomes.
Jennifer S Spence, Ruina He, Hans-Heinrich Hoffmann, Tandrila Das, Emmanuelle Thinon, Charles M Rice, Tao Peng, Kartik Chandran, Howard C Hang. Nat Chem Biol 2019
85
40

Interferon-induced transmembrane proteins inhibit cell fusion mediated by trophoblast syncytins.
Ashley Zani, Lizhi Zhang, Temet M McMichael, Adam D Kenney, Mahesh Chemudupati, Jesse J Kwiek, Shan-Lu Liu, Jacob S Yount. J Biol Chem 2019
29
40

IFITMs restrict the replication of multiple pathogenic viruses.
Jill M Perreira, Christopher R Chin, Eric M Feeley, Abraham L Brass. J Mol Biol 2013
145
40


MARCH8 inhibits viral infection by two different mechanisms.
Yanzhao Zhang, Takuya Tada, Seiya Ozono, Satoshi Kishigami, Hideaki Fujita, Kenzo Tokunaga. Elife 2020
13
40

Early Vertebrate Evolution of the Host Restriction Factor Tetherin.
Elena Heusinger, Silvia F Kluge, Frank Kirchhoff, Daniel Sauter. J Virol 2015
18
40

Localization to detergent-resistant membranes and HIV-1 core entry inhibition correlate with HIV-1 restriction by SERINC5.
Bianca Schulte, Anastasia Selyutina, Silvana Opp, Alon Herschhorn, Joseph G Sodroski, Massimo Pizzato, Felipe Diaz-Griffero. Virology 2018
23
40

Origins and Evolution of tetherin, an Orphan Antiviral Gene.
Daniel Blanco-Melo, Siddarth Venkatesh, Paul D Bieniasz. Cell Host Microbe 2016
15
40

HIV-1 Nef Antagonizes SERINC5 Restriction by Downregulation of SERINC5 via the Endosome/Lysosome System.
Jing Shi, Ran Xiong, Tao Zhou, Peiyi Su, Xihe Zhang, Xusheng Qiu, Hongmei Li, Sunan Li, Changqing Yu, Bin Wang,[...]. J Virol 2018
49
40

IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise.
Julian Buchrieser, Séverine A Degrelle, Thérèse Couderc, Quentin Nevers, Olivier Disson, Caroline Manet, Daniel A Donahue, Françoise Porrot, Kenzo-Hugo Hillion, Emeline Perthame,[...]. Science 2019
51
40

S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3.
Ajit Chande, Emilia Cristiana Cuccurullo, Annachiara Rosa, Serena Ziglio, Susan Carpenter, Massimo Pizzato. Proc Natl Acad Sci U S A 2016
48
40


Evolution-guided identification of antiviral specificity determinants in the broadly acting interferon-induced innate immunity factor MxA.
Patrick S Mitchell, Corinna Patzina, Michael Emerman, Otto Haller, Harmit S Malik, Georg Kochs. Cell Host Microbe 2012
95
40

The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles.
Birthe Trautz, Hannah Wiedemann, Christian Lüchtenborg, Virginia Pierini, Jan Kranich, Bärbel Glass, Hans-Georg Kräusslich, Thomas Brocker, Massimo Pizzato, Alessia Ruggieri,[...]. J Biol Chem 2017
45
40

Structure and Dynamics of the Native HIV-1 Env Trimer.
James B Munro, Walther Mothes. J Virol 2015
52
40

IFITM proteins inhibit HIV-1 protein synthesis.
Wing-Yiu Jason Lee, Rebecca Menhua Fu, Chen Liang, Richard D Sloan. Sci Rep 2018
21
40

Escape of HIV-1 envelope glycoprotein from the restriction of infection by IFITM3.
Aurélie Drouin, Julie Migraine, Marie-Alice Durand, Alain Moreau, Julien Burlaud-Gaillard, Maxime Beretta, Philippe Roingeard, Mélanie Bouvin-Pley, Martine Braibant. J Virol 2020
3
66


Homology-guided identification of a conserved motif linking the antiviral functions of IFITM3 to its oligomeric state.
Kazi Rahman, Charles A Coomer, Saliha Majdoul, Selena Y Ding, Sergi Padilla-Parra, Alex A Compton. Elife 2020
18
40

Maturation-dependent HIV-1 surface protein redistribution revealed by fluorescence nanoscopy.
Jakub Chojnacki, Thorsten Staudt, Bärbel Glass, Pit Bingen, Johann Engelhardt, Maria Anders, Jale Schneider, Barbara Müller, Stefan W Hell, Hans-Georg Kräusslich. Science 2012
167
40

HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes.
Kosuke Miyauchi, Yuri Kim, Olga Latinovic, Vladimir Morozov, Gregory B Melikyan. Cell 2009
472
40

Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs.
Kevin Tartour, Xuan-Nhi Nguyen, Romain Appourchaux, Sonia Assil, Véronique Barateau, Louis-Marie Bloyet, Julien Burlaud Gaillard, Marie-Pierre Confort, Beatriz Escudero-Perez, Henri Gruffat,[...]. PLoS Pathog 2017
35
40

IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion.
Tanay M Desai, Mariana Marin, Christopher R Chin, George Savidis, Abraham L Brass, Gregory B Melikyan. PLoS Pathog 2014
178
40

The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization.
Rui Jia, Qinghua Pan, Shilei Ding, Liwei Rong, Shan-Lu Liu, Yunqi Geng, Wentao Qiao, Chen Liang. J Virol 2012
119
40


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.